HEXO (TSX:HEXO): An Attractive Cannabis Pick Right Now

After a weaker-than-expected third-quarter performance, Hexo Corp. stock may still be an attractive buy for investors to consider for their investment portfolios.

| More on:
edit Jars of marijuana

Image source: Getty Images

Hexo (TSX:HEXO)(NYSE:HEXO) had a disappointing performance in the third quarter of fiscal 2020 based on its quarterly earnings report released earlier this month.

Analyst expectations from the quarter were that the company’s top line would reach $34.5 million and end the quarter with $0.06 per share in losses. Unfortunately, the company’s top line came below $23 million, and its net losses were at $0.17 per share — significantly higher than expectations.

It came as no surprise that the quarterly earnings report triggered a significant drop in its share prices. However, Hexo stock might not be a bad pick to consider adding to your portfolio if you are bullish on the cannabis sector.

I will discuss Hexo’s third-quarter performance and its growth prospects to help you make a more well-informed decision regarding whether it is a good stock pick to consider.

A disappointing quarter

The last quarter saw the company’s revenue dip by more than 30%. The company’s management has blamed the devastating revenue loss on certain production decisions for its hash segment and mistimed strain cultivation. However, Hexo’s management has said that it has corrected the problems and expects its sales to rebound in the coming few quarters.

Hexo retains its leading position in the cannabis-infused beverage industry, despite its recent losses. The company’s adjusted EBITDA fell to a loss of $10.8 million due to weaker sales — a massive decline from its adjusted EBITDA of $0.2 million in the previous quarter. Hexo’s management has managed to raise funds through equity offerings and debt facilities to improve its balance sheet.

Promising outlook for growth

The company ended its third quarter for this fiscal year with $194 million in cash and another $275 million in escrow to complete its acquisition of Redecan. To make things better for the company, its joint venture with Molson Coors Canada has acquired almost half of the total beverage segment share in the Canadian market. Truss Beverage, the combined venture between Hexo and Molson Coors, also launched six additional products in April 2021.

Hexo is also introducing hash products to the market containing higher THC concentrations to regain momentum in the market. Hexo is also focusing on its acquisition-based growth to establish a stronger presence in the market. The company recently acquired Zenabis, allowing it to expand its domestic presence and improve its production capacity.

The acquisition has also helped Hexo establish a foothold in the European markets. Hexo’s management is currently working on the Redecan acquisition, along with other lucrative deals for the company. Successful acquisitions will significantly improve Hexo’s balance sheet, expand its reach, add more diversity to its product portfolio, and deliver accretive synergies.

The company also looks well positioned to cater to the U.S. market by buying a 50,000-sq.-ft. facility in Colorado.

Foolish takeaway

The third-quarter performance for Hexo was weaker than analysts anticipated. Several analysts have adjusted their price target average for the stock to $8.85 per share. Trading for $7.22 per share at writing, Hexo still has some upside to reach that price target.

Hexo stock still has its fair share of short-term challenges to contend with. However, the company’s growth prospects are promising. Trading for a 44% discount from its February 2021 high, Hexo could be a good addition to your portfolio if you believe that it can fulfill its upside potential in the coming years.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Adam Othman has no position in any of the stocks mentioned. The Motley Fool recommends HEXO Corp.

More on Cannabis Stocks

Cannabis grows at a commercial farm.
Cannabis Stocks

Down 99% From All-Time Highs, Is Canopy Growth Stock a Good Buy Right Now?

Canopy Growth stock is a high-risk investment due to its negative profit margins and challenging liquidity position.

Read more »

Marijuana plant and cannabis oil bottles isolated
Stocks for Beginners

Aurora Cannabis’ Reverse Stock Split: Is the Stock a Buy Today?

Cannabis stock Aurora (TSX:ACB) is consolidating shares once again, but what does this mean for investors?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Where Will Cannabis Stocks Be in 10 Years?

Cannabis stocks could see a huge shift upwards should marijuana be rescheduled in the U.S., but you can still buy…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Forget Canopy Growth: 1 Cannabis Stock With Far Less Risk

Cannabis stocks like Canopy Growth (TSX:WEED) haven't done well for quite some time, yet this one deserves a major boost!

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Canopy Growth Stock Worth Buying?

Canopy Growth stock (TSX:WEED) made a big move to consolidate its shares, but will this help the company move forward?

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Corp: Will it Ever Be a Buy?

Canopy Growth Corp (TSX:WEED) keeps going lower. Will it ever find a bottom?

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Are Cannabis Stocks a Good Buy in November 2023?

Cannabis stocks have slumped a long way down in the last few years, so is November the time to get…

Read more »

A cannabis plant grows.
Cannabis Stocks

2 Top Cannabis Stocks to Buy on the TSX Today

Two cannabis stocks are the top picks as the market moves toward consolidation and stability.

Read more »